Valuation
ADAPAdaptimmune Therapeutics
StockStockUnited StatesHealth careEU retail investors: available
0.0% today · −50.0% over a year
No score: too little data.
No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | ADAP | Sector median | vs median |
|---|---|---|---|
| P/E | — | 29.2 · n=157 | — |
| P/B | — | 3.8 · n=306 | — |
| P/S | — | 4.1 · n=299 | — |
| EV/EBIT | — | 25.6 · n=145 | — |
| Free-cash-flow yield | — | 1.5% · n=288 | — |
| Dividend yield | 0.00% | 0.00% · n=361 | — |
| Return on equity | — | −2.2% · n=305 | — |
| Return on invested capital | — | 0.7% · n=279 | — |
| Gross margin | — | 63.4% · n=204 | — |
| Net debt / EBITDA | — | 1.27 · n=149 | — |
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 46.2 | 31.6 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 41.3 | 8.2 | — | 3.1% | 1.9% | 8/10 |
| ABBVAbbVie | 50.0 | — | 27.6 | 3.7% | 2.9% | 6/10 |
| MRKMerck | 147.5 | 8.1 | — | 4.1% | 2.3% | 8/10 |
| UNHUnitedHealth | 22.2 | 3.4 | 16.9 | 6.5% | 2.3% | 10/10 |
| TMOThermo Fisher Scientific | 36.4 | 4.7 | 34.5 | 3.0% | 0.3% | 9/10 |
| AMGNAmgen | 26.5 | 17.4 | 23.0 | 3.8% | 2.2% | 8/10 |
| GILDGilead Sciences | — | 15.9 | — | 6.7% | 1.9% | 4/10 |
| ABTAbbott | 40.5 | 3.7 | 32.8 | 3.5% | 2.8% | 6/10 |
| PFEPfizer | 41.5 | 1.9 | — | 7.0% | 7.3% | 1/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.